AEGiS-AP: Lawmakers Urge Acceptance of AIDS Drugs Associated PressImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


Lawmakers Urge Acceptance of AIDS Drugs

Associated Press - March 26, 2004


WASHINGTON - The White House should not push for more stringent standards on lower-cost AIDS drugs to be used to combat the disease in Africa, because the World Health Organization already has approved the medicines, lawmakers said Friday.

Setting up an American system when WHO has approved the drugs would delay delivery of AIDS medicines to people who need them, said Rep. Henry Waxman, D-Calif., and Sens. Edward Kennedy, D-Mass., and John McCain, R-Ariz., in separate letters to the White House.

"Make no mistake, delays will cost lives," Kennedy and McCain said in their letter.

Waxman accused the White House of putting the consideration of American drug companies above getting generic low-cost medicines, most of which are made in India, to dying Africans.

"These pharmaceutical companies are among your strongest political supporters," Waxman said. "They should not be dictating policy on U.S. efforts to fight HIV/AIDS in Africa and elsewhere."

At issue is a scheduled meeting in Botswana to discuss whether stringent safety and efficiency standards should be applied to "fixed-dose combination" drugs, which combine several different treatments for the disease into one pill.

Some of these medicines already have been cleared by the WHO, but some Bush administration officials have suggested an American review system is necessary. The American proposal will be discussed in Botswana March 29-30.

The lawmakers said WHO's standards are sometimes higher than the American standards, and trying to set up another review system will just slow down attempts to get low-cost drugs to African countries.


040326
AP040356


Copyright © 2004 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .